Medication-info.com Search Menu

Glydo: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
20 mg/mL
Other brand names:
Drug class:
Active ingredient:
Similar drugs:

Source: FDA drug labeling via NLM DailyMed · About this document

Patient information: uses, side effects, how to take - Glydo

INSTRUCTIONS FOR USE

Please note: The blister package contains a sterile syringe.

Do not open the blister until ready to use.

  1. 1. When ready to use, open the blister and drop the syringe onto a sterile field.
  2. 2. Before removing the tip cap, press in the plunger to remove any resistance that may be present. This helps ensure that the syringe will empty easily and uniformly.
  3. 3. Remove the tip cap from the syringe. The syringe is now ready for use.
  4. 4. GLYDO (lidocaine HCl jelly, USP) 2% should be instilled slowly and evenly into the urethra. See the DOSAGE AND ADMINISTRATION section for additional details.
  5. 5. Wait for a few minutes after instillation of GLYDO (lidocaine HCl jelly, USP) 2% for the anesthetic to take full effect. Full anesthetic effect will occur in 5 to 10 minutes after complete instillation.
  6. 6. Any gel not used in a single application must be discarded.

sagent ®

Mfd. for SAGENT Pharmaceuticals

Schaumburg, IL 60173 (USA)

Mfd. by Klosterfrau Berlin GmbH

Made in Germany

©2025 Sagent Pharmaceuticals

Revised: May 2025

This “Instructions for Use” has been approved by the U.S. Food and Drug Administration.

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: ANDA 201094 · View the label on DailyMed

Revision date stated in the text: May 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Glydo

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Amide Local Anesthetic, Antiarrhythmic
Active ingredient Lidocaine hydrochloride anhydrous 20 mg/mL
Dosage form Jelly
Route Topical
Marketing status listed in the FDA NDC Directory
Company (applicant) SAGENT PHARMS INC
FDA approval ANDA 201094Abbreviated New Drug Application (ANDA) – generic drug Approved April 28, 2014
Therapeutic equivalence (TE) code ATCodes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book).
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
20 mg/mL – 6 ml in 1 syringe / 10 in 1 carton
20 mg/mL – 11 ml in 1 syringe / 10 in 1 carton

Source: FDA drug labeling via NLM DailyMed, data as of November 3, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.